(Q74344164)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12079713%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

The use of recombinant thyrotropin in the follow-up of patients with differentiated thyroid cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12079713%20AND%20SRC:MED&resulttype=core&format=json

differentiated thyroid carcinoma

10 November 2019

main subject

1 reference

Milena Basaria

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12079713%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Hans Graf

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12079713%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

David S Cooper

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12079713%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 June 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12079713%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12079713%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12079713%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12079713%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

721-725

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12079713%20AND%20SRC:MED&resulttype=core&format=json

Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901120-8

Thyroid cancer: a lethal endocrine neoplasm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901120-8

Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901120-8

Detection of residual and recurrent thyroid cancer by radionuclide imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901120-8

Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901120-8

Pharmacology of bovine and human thyrotropin: an historical perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901120-8

Recombinant human thyroid-stimulating hormone: initial bioactivity assessment using human fetal thyroid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901120-8

Effect of various doses of recombinant human thyrotropin on the thyroid radioactive iodine uptake and serum levels of thyroid hormones and thyroglobulin in normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901120-8

Comparison of Administration of Recombinant Human Thyrotropin with Withdrawal of Thyroid Hormone for Radioactive Iodine Scanning in Patients with Thyroid Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901120-8

Recombinant thyrotropin versus thyroid hormone withdrawal in evaluating patients with thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901120-8

Using recombinant human TSH in the management of well-differentiated thyroid cancer: current strategies and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901120-8

Clinical use of recombinant human TSH in thyroid cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901120-8

Papillary thyroid carcinoma metastatic to the pituitary gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901120-8

Exacerbation of renal failure due to hypothyroidism in a patient with ischemic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901120-8

Natural history, treatment, and course of papillary thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901120-8

Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901120-8

Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131I and recombinant human thyroid stimulating hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901120-8

Hemiplegia after thyrotropin alfa in a hypothyroid patient with thyroid carcinoma metastatic to the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901120-8

Compassionate use of recombinant human thyrotropin to facilitate radioiodine therapy: case report and review of literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901120-8

Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901120-8

Sudden enlargement of local recurrent thyroid tumor after recombinant human TSH administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901120-8

The use of recombinant human TSH in the follow-up of differentiated thyroid cancer: experience from a large patient cohort in a single centre

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901120-8

Use of recombinant human thyrotropin before radioiodine therapy in patients with advanced differentiated thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901120-8

10.1016/S0002-9343(02)01120-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12079713%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference